Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates

Experimental Dermatology

Volumn 12, Issue 5, 2003, Pages 682-691

  Rustemeyer, T ^a   Preuss, M ^a   Von Blomberg, B M E ^a   Das, P K ^b   Scheper, R J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Allergenicity; Chemokine receptor; Dendritic cells; In vitro testing; Skin organ culture

Indexed keywords

B7 ANTIGEN; BIOCHEMICAL MARKER; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CONTACT ALLERGEN; CROTON OIL; DODECYL SULFATE SODIUM; GLYCOPROTEIN P; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; IRRITANT AGENT; LUNG RESISTANCE PROTEIN; METHACRYLIC ACID DERIVATIVE; METHACRYLIC ACID METHYL ESTER; MULTIDRUG RESISTANCE PROTEIN; T6 ANTIGEN;

ADULT; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; COMPARATIVE STUDY; CONTACT ALLERGY; CONTACT SENSITIZATION; CONTROLLED STUDY; CORRELATION FUNCTION; DENDRITIC CELL; EX VIVO STUDY; EXPLANT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MODEL; MONOCYTE; PROTEIN EXPRESSION; RELIABILITY; SCREENING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SKIN CULTURE; SKIN STRUCTURE; STAINING; TYPES OF STUDY;

CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DERMATITIS, CONTACT; HAPTENS; HUMANS; METHACRYLATES; ORGAN CULTURE TECHNIQUES; SIGNAL TRANSDUCTION;

EID: 0142025143     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2003.00077.x     Document Type: Article

References (36)

1. Rustemeyer T, Frosch P J. Occupational skin diseases in dental laboratory technicians. (I). Clinical picture and causative factors. Contact Dermatitis 1996: 34: 125-133.
2. Kanerva L, Alanko K, Estlander T, Jolanki R, Lahtinen A, Savela A. Statistics on occupational contact dermatitis from (meth) acrylates in dental personnel. Contact Dermatitis 2000: 42: 175-176.
3. Rustemeyer T, Frosch P J. Occupational contact dermatitis in dental personnel. In: Kamverva L, Elsner P, Wahlberg J E, Maibach H I, eds. Handbook of Occupational Dermatology. Berlin: Springer Verlag, 2000: 899-905.
4. Peiler D, Rustemeyer Pflug B, Frosch P. Occupational skin diseases in dental laboratory technicians. (II) Major allergens their clinical relevance (in press).
5. Kanerva L, Estlander T, Jolanki R, Tarvainen K. Occupational allergic contact dermatitis caused by exposure to acrylates during work with dental prostheses. Contact Dermatitis 1993: 28: 268-275.
6. Kanerva L, Jolanki R, Leino T, Estlander T. Occupational allergic contact dermatitis from 2-hydroxethyl methacrylate and ethylene glycol dimethacrylate in a modified acrylic structural adhesive. Contact Dermatitis 1995: 3: 84-89.
7. Kiec-Swiercznska M. Occupational allergic contact dermatitis due to acrylates in Lodz. Contact Dermatitis 1996: 34: 419-422.
8. Björkner B. Contact allergy to 2-hydroxypropyl methacrylate (2-HPMA) in an ultraviolet curable ink. Acta Derm Venerol (Stockh) 1984: 64: 264-2764.
9. Van Der Walle H B, Klecak G, Geleick H, Bensink T. Sensitizing potential of 14 mono (meth) acrylates in the guinea pig. Contact Dermatitis 1982: 8: 223-235.
10. Van Der Walle H B, Waegemaekers T, Bensink T. Sensitizing potential of 12 di (meth) acrylates in the guinea pig. Contact Dermatitis 1983: 9: 10-20.
11. Krasteva M, Peguet-Navarro J, Moulon C, Courtellemont P, Redziniak G, Schmitt D. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells - A screening predictive assay for contact sensitizers. Clin Exp Allergy 1996: 26: 563-570.
12. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C. In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 2000: 145: 73-82.
13. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumour necrosis factor alpha. J Exp Med 1994: 179: 1109-1118.
14. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Down-regulation by cytokines and bacterial products. J Exp Med 1995: 182: 389-400.
15. Lanzavecchia A. Dendritic cell maturation and generation of immune responses. Haematologica 1999: 84: 23-25.
16. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000: 18: 217-242.
17. Borst P, Evers R, Kook M, Wijnholds J. The multidrug resistance protein family. Biochem Biophys Acta 1999: 1461: 347-357.
18. Covelli A. Modulation of multidrug resistance (MDR) in hematological malignancies. Ann Oncol 1999: 10 (Suppl. 6): 53-59.
19. Izquierdo M A, Shoemaker Rh, Flens M J et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996: 65: 1-8.
20. Schroeijers A B, Reurs A W, Scheffer G L et al. Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol 2002: 168: 1572-1578.
21. Randolph G J, Beaulieu S, Pope M et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci USA 1998: 95: 6924-6929.
22. Pistoor F H M, Rambukkana A, Kroezen M et al. Novel predictive assay for contact allergens using human skin explants cultures. Am J Pathol 1996: 149: 337-343.
23. Rambukkana A, Pistoor F H M, Bos J D, Kaspenberg M L, Das P K. Effects of contact allergens on human Langerhans cells in skin organ culture: Migration, modulation of cell surface molecules, and early expression of interleukin-1β protein. Laboratory Invest 1996: 74: 422-436.
24. Rustenmeyer T, De Ligter S, Von Blomberg B M E, Frosch P J, Scheper R J. Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clin Exp Immunol 1999: 117: 209-216.
25. Coligan J E, Kruisbeek A M, Marguiles D H, Shevach E M, Strober W, eds. Current Protocols in Immunology, 1st ed. New York: Greene & Wiley, 1991: 7.1-7.8.
26. Fleiss J L. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons, 1981.
27. Aiba S, Terenuma A, Manome H, Tagami H. Dendritic cells differentially respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997: 27: 3031-3038.
28. Degwert J, Steckel F, Hoppe U, Kligman L H. In vitro model for contact sensitization. 1. Stimulatory capacities of human blood-derived phenotypical alterations in the presence of contact sensitizers. Toxicol Vitro 1997: 11: 613-618.
29. Schroeijers A B, Izquierdo M A, Scheffner G L, Wiemer E A C, Scheper R J. Vaults and LRP/MVP. Biology and expression in cancer. In: Dalton W S, ed. Determinants of Drug Response and Drug Resistance in Cancer. Amsterdam: Kluwer Academic Publisher (in press).
30. Scheffer G L, Wijngaard P L J, Flens M J et al. The drug-resistance-related protein LRP is the human major vault protein. Nature Med 1995: 1: 578-582.
31. Müller G, Knop J, Enk A H. Is cytokine expression responsible for differences between allergens and irritants? Am J Contact Dermatitis 1996: 7: 177-184.
32. Aiba S, Manome H, Yoshito Y, Tagami H. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 2000: 101: 68-75.
33. Tuschl H, Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol in Vitro 2001: 15: 327-331.
34. Rambukkana A, Irik D, Le Poole I C, Kapsenberg M L, Bos J D, Das P K. In situ behavior of human Langerhans cells in skin organ culture. Laboratory Invest 1995: 73: 521-531.
35. Kaverva L, Jolanki R, Estlander T. 10 years of patch testing with the (meth) acrylate series. Contact Dermatitis 1997: 37: 255-258.
36. Schnuch A, Uter W, Geier J, Frosch P J, Rustemeyer T. Contact allergies in healthcare workers. Results from the IVDK. Acta Derm Venerol 1998: 78: 358-363.